A citation-based method for searching scientific literature

Lukas Farbiak, Qiang Cheng, Tuo Wei, Ester Álvarez-Benedicto, Lindsay T Johnson, Sang Lee, Daniel J Siegwart. Adv Mater 2021
Times Cited: 22







List of co-cited articles
259 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing.
Qiang Cheng, Tuo Wei, Lukas Farbiak, Lindsay T Johnson, Sean A Dilliard, Daniel J Siegwart. Nat Nanotechnol 2020
352
59

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing.
Jonathan D Finn, Amy Rhoden Smith, Mihir C Patel, Lucinda Shaw, Madeleine R Youniss, Jane van Heteren, Tanner Dirstine, Corey Ciullo, Reynald Lescarbeau, Jessica Seitzer,[...]. Cell Rep 2018
322
40

A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.
Martin Jinek, Krzysztof Chylinski, Ines Fonfara, Michael Hauer, Jennifer A Doudna, Emmanuelle Charpentier. Science 2012
40

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis.
Julian D Gillmore, Ed Gane, Jorg Taubel, Justin Kao, Marianna Fontana, Michael L Maitland, Jessica Seitzer, Daniel O'Connell, Kathryn R Walsh, Kristy Wood,[...]. N Engl J Med 2021
293
40

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs.
Akin Akinc, Martin A Maier, Muthiah Manoharan, Kevin Fitzgerald, Muthusamy Jayaraman, Scott Barros, Steven Ansell, Xinyao Du, Michael J Hope, Thomas D Madden,[...]. Nat Nanotechnol 2019
362
36

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.
Alexis C Komor, Yongjoo B Kim, Michael S Packer, John A Zuris, David R Liu. Nature 2016
31

Membrane-destabilizing ionizable phospholipids for organ-selective mRNA delivery and CRISPR-Cas gene editing.
Shuai Liu, Qiang Cheng, Tuo Wei, Xueliang Yu, Lindsay T Johnson, Lukas Farbiak, Daniel J Siegwart. Nat Mater 2021
88
31

Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing.
Tuo Wei, Qiang Cheng, Yi-Li Min, Eric N Olson, Daniel J Siegwart. Nat Commun 2020
156
31

Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3.
Min Qiu, Zachary Glass, Jinjin Chen, Mary Haas, Xin Jin, Xuewei Zhao, Xuehui Rui, Zhongfeng Ye, Yamin Li, Feng Zhang,[...]. Proc Natl Acad Sci U S A 2021
69
31

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy.
Daniel Rosenblum, Anna Gutkin, Ranit Kedmi, Srinivas Ramishetti, Nuphar Veiga, Ashley M Jacobi, Mollie S Schubert, Dinorah Friedmann-Morvinski, Zvi R Cohen, Mark A Behlke,[...]. Sci Adv 2020
103
27

Lipid Nanoparticle Systems for Enabling Gene Therapies.
Pieter R Cullis, Michael J Hope. Mol Ther 2017
332
27

Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.
Piotr S Kowalski, Arnab Rudra, Lei Miao, Daniel G Anderson. Mol Ther 2019
350
27

Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain.
Saed Abbasi, Satoshi Uchida, Kazuko Toh, Theofilus A Tockary, Anjaneyulu Dirisala, Kotaro Hayashi, Shigeto Fukushima, Kazunori Kataoka. J Control Release 2021
19
26

Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair.
Kunwoo Lee, Michael Conboy, Hyo Min Park, Fuguo Jiang, Hyun Jin Kim, Mark A Dewitt, Vanessa A Mackley, Kevin Chang, Anirudh Rao, Colin Skinner,[...]. Nat Biomed Eng 2017
370
22

Rational designs of in vivo CRISPR-Cas delivery systems.
Cong-Fei Xu, Guo-Jun Chen, Ying-Li Luo, Yue Zhang, Gui Zhao, Zi-Dong Lu, Anna Czarna, Zhen Gu, Jun Wang. Adv Drug Deliv Rev 2021
59
22

A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing.
Guojun Chen, Amr A Abdeen, Yuyuan Wang, Pawan K Shahi, Samantha Robertson, Ruosen Xie, Masatoshi Suzuki, Bikash R Pattnaik, Krishanu Saha, Shaoqin Gong. Nat Nanotechnol 2019
129
22

Fast and Efficient CRISPR/Cas9 Genome Editing In Vivo Enabled by Bioreducible Lipid and Messenger RNA Nanoparticles.
Ji Liu, Jin Chang, Ying Jiang, Xiandi Meng, Tianmeng Sun, Lanqun Mao, Qiaobing Xu, Ming Wang. Adv Mater 2019
132
22

Optimization of Lipid Nanoparticle Formulations for mRNA Delivery in Vivo with Fractional Factorial and Definitive Screening Designs.
Kevin J Kauffman, J Robert Dorkin, Jung H Yang, Michael W Heartlein, Frank DeRosa, Faryal F Mir, Owen S Fenton, Daniel G Anderson. Nano Lett 2015
266
22

Cell specific delivery of modified mRNA expressing therapeutic proteins to leukocytes.
Nuphar Veiga, Meir Goldsmith, Yasmin Granot, Daniel Rosenblum, Niels Dammes, Ranit Kedmi, Srinivas Ramishetti, Dan Peer. Nat Commun 2018
111
22

Dendrimer-Based Lipid Nanoparticles Deliver Therapeutic FAH mRNA to Normalize Liver Function and Extend Survival in a Mouse Model of Hepatorenal Tyrosinemia Type I.
Qiang Cheng, Tuo Wei, Yuemeng Jia, Lukas Farbiak, Kejin Zhou, Shuyuan Zhang, Yonglong Wei, Hao Zhu, Daniel J Siegwart. Adv Mater 2018
75
22

Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.
Kejin Zhou, Liem H Nguyen, Jason B Miller, Yunfeng Yan, Petra Kos, Hu Xiong, Lin Li, Jing Hao, Jonathan T Minnig, Hao Zhu,[...]. Proc Natl Acad Sci U S A 2016
84
22

Engineering precision nanoparticles for drug delivery.
Michael J Mitchell, Margaret M Billingsley, Rebecca M Haley, Marissa E Wechsler, Nicholas A Peppas, Robert Langer. Nat Rev Drug Discov 2021
912
22

In vivo adenine base editing of PCSK9 in macaques reduces LDL cholesterol levels.
Tanja Rothgangl, Melissa K Dennis, Paulo J C Lin, Rurika Oka, Dominik Witzigmann, Lukas Villiger, Weihong Qi, Martina Hruzova, Lucas Kissling, Daniela Lenggenhager,[...]. Nat Biotechnol 2021
84
22

RNA-guided human genome engineering via Cas9.
Prashant Mali, Luhan Yang, Kevin M Esvelt, John Aach, Marc Guell, James E DiCarlo, Julie E Norville, George M Church. Science 2013
18


Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage.
Nicole M Gaudelli, Alexis C Komor, Holly A Rees, Michael S Packer, Ahmed H Badran, David I Bryson, David R Liu. Nature 2017
18

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing.
Danny Wilbie, Johanna Walther, Enrico Mastrobattista. Acc Chem Res 2019
108
18

Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs.
Yao Lin, Jiahua Wu, Weihuai Gu, Yulei Huang, Zhongchun Tong, Lijia Huang, Jiali Tan. Adv Sci (Weinh) 2018
211
18

DNA targeting specificity of RNA-guided Cas9 nucleases.
Patrick D Hsu, David A Scott, Joshua A Weinstein, F Ann Ran, Silvana Konermann, Vineeta Agarwala, Yinqing Li, Eli J Fine, Xuebing Wu, Ophir Shalem,[...]. Nat Biotechnol 2013
18

Multiplex genome engineering using CRISPR/Cas systems.
Le Cong, F Ann Ran, David Cox, Shuailiang Lin, Robert Barretto, Naomi Habib, Patrick D Hsu, Xuebing Wu, Wenyan Jiang, Luciano A Marraffini,[...]. Science 2013
18

Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.
Hao Yin, Chun-Qing Song, Joseph R Dorkin, Lihua J Zhu, Yingxiang Li, Qiongqiong Wu, Angela Park, Junghoon Yang, Sneha Suresh, Aizhan Bizhanova,[...]. Nat Biotechnol 2016
556
18

Helper lipid structure influences protein adsorption and delivery of lipid nanoparticles to spleen and liver.
Rui Zhang, Rakan El-Mayta, Timothy J Murdoch, Claude C Warzecha, Margaret M Billingsley, Sarah J Shepherd, Ningqiang Gong, Lili Wang, James M Wilson, Daeyeon Lee,[...]. Biomater Sci 2021
21
19

Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing.
Tuo Wei, Qiang Cheng, Lukas Farbiak, Daniel G Anderson, Robert Langer, Daniel J Siegwart. ACS Nano 2020
34
18


Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA.
Jason B Miller, Shuyuan Zhang, Petra Kos, Hu Xiong, Kejin Zhou, Sofya S Perelman, Hao Zhu, Daniel J Siegwart. Angew Chem Int Ed Engl 2017
295
18

Functionalized lipid-like nanoparticles for in vivo mRNA delivery and base editing.
Xinfu Zhang, Weiyu Zhao, Giang N Nguyen, Chengxiang Zhang, Chunxi Zeng, Jingyue Yan, Shi Du, Xucheng Hou, Wenqing Li, Justin Jiang,[...]. Sci Adv 2020
48
18

Carboxylated branched poly(β-amino ester) nanoparticles enable robust cytosolic protein delivery and CRISPR-Cas9 gene editing.
Yuan Rui, David R Wilson, John Choi, Mahita Varanasi, Katie Sanders, Johan Karlsson, Michael Lim, Jordan J Green. Sci Adv 2019
64
18

Polymer-Lipid Nanoparticles for Systemic Delivery of mRNA to the Lungs.
James C Kaczmarek, Asha K Patel, Kevin J Kauffman, Owen S Fenton, Matthew J Webber, Michael W Heartlein, Frank DeRosa, Daniel G Anderson. Angew Chem Int Ed Engl 2016
134
18

Delivering CRISPR: a review of the challenges and approaches.
Christopher A Lino, Jason C Harper, James P Carney, Jerilyn A Timlin. Drug Deliv 2018
425
18

Genome editing. The new frontier of genome engineering with CRISPR-Cas9.
Jennifer A Doudna, Emmanuelle Charpentier. Science 2014
18

Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.
Hao Yin, Chun-Qing Song, Sneha Suresh, Qiongqiong Wu, Stephen Walsh, Luke Hyunsik Rhym, Esther Mintzer, Mehmet Fatih Bolukbasi, Lihua Julie Zhu, Kevin Kauffman,[...]. Nat Biotechnol 2017
240
18

Cationic lipid-mediated delivery of proteins enables efficient protein-based genome editing in vitro and in vivo.
John A Zuris, David B Thompson, Yilai Shu, John P Guilinger, Jeffrey L Bessen, Johnny H Hu, Morgan L Maeder, J Keith Joung, Zheng-Yi Chen, David R Liu. Nat Biotechnol 2015
831
18

Lipid nanoparticle technology for therapeutic gene regulation in the liver.
Dominik Witzigmann, Jayesh A Kulkarni, Jerry Leung, Sam Chen, Pieter R Cullis, Roy van der Meel. Adv Drug Deliv Rev 2020
85
18

Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.
Ming Wang, John A Zuris, Fantao Meng, Holly Rees, Shuo Sun, Pu Deng, Yong Han, Xue Gao, Dimitra Pouli, Qi Wu,[...]. Proc Natl Acad Sci U S A 2016
344
18

Lipid nanoparticles for mRNA delivery.
Xucheng Hou, Tal Zaks, Robert Langer, Yizhou Dong. Nat Rev Mater 2021
317
18

Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications.
Chang Liu, Li Zhang, Hao Liu, Kun Cheng. J Control Release 2017
238
18

Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles.
James C Kaczmarek, Asha Kumari Patel, Luke H Rhym, Umberto Capasso Palmiero, Balkrishen Bhat, Michael W Heartlein, Frank DeRosa, Daniel G Anderson. Biomaterials 2021
16
25

Ionizable Lipid Nanoparticle-Mediated mRNA Delivery for Human CAR T Cell Engineering.
Margaret M Billingsley, Nathan Singh, Pranali Ravikumar, Rui Zhang, Carl H June, Michael J Mitchell. Nano Lett 2020
133
18

Genome engineering using the CRISPR-Cas9 system.
F Ann Ran, Patrick D Hsu, Jason Wright, Vineeta Agarwala, David A Scott, Feng Zhang. Nat Protoc 2013
13

Uridine Depletion and Chemical Modification Increase Cas9 mRNA Activity and Reduce Immunogenicity without HPLC Purification.
Sriram Vaidyanathan, Krist T Azizian, A K M Ashiqul Haque, Jordana M Henderson, Ayal Hendel, Sabrina Shore, Justin S Antony, Richard I Hogrefe, Michael S D Kormann, Matthew H Porteus,[...]. Mol Ther Nucleic Acids 2018
96
13


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.